BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  PolarityTE Lead Product, SkinTE, is Approved for Use by Multiple Medical Institutions

  Clinical application is expected in the fourth quarter of 2017, and data is planned to be released through multiple channels in the first half of 2018.

  October 19, 2017

   · 

  5 min read
• Bio-Rad Release: Genomics Researchers Showcase Their Applications Of Droplet Digital PCR At ASHG 2017 Annual Meeting

  The sensitivity and reliability of Droplet Digital PCR will be showcased in over a dozen presentations at the American Society of Human Genetics (ASHG) 2017 Annual Meeting, Orlando, Fla., October 17-21.

  October 19, 2017

   · 

  4 min read
• Biotech Bay

  Zogenix: High Seizure Frequency in Children With Dravet Syndrome Negatively Impacts Quality of Life, New International Caregiver Survey Finds

  The results suggest a need for more effective antiepileptic treatments.

  October 19, 2017

   · 

  5 min read
• Business

  Harvard Bioscience Schedules Third Quarter 2017 Conference Call for October 26 at 4:30 PM ET

  A conference call to discuss the company’s third quarter 2017 financial results and its operations is scheduled for that same date at 4:30 PM ET.

  October 19, 2017

   · 

  1 min read
• MedDay To Participate In The 7th Joint ECTRIMS - ACTRIMS Meeting In Paris, France

  MedDay announces that it will be participating in the 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) -Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) meeting, to be held from 25-28 October 2017 in Paris, France.

  October 19, 2017

   · 

  5 min read
• Drug Development

  Creative Medical Technology Announces Commercialization of Patented Stem Cell Procedure for Erectile Dysfunction

  Creative Medical Technology Holdings announced today completion of the safety data analysis on 20 patients with pharmacologically-resistant erectile dysfunction treated with the Company’s patented CaverStem procedure.

  October 19, 2017

   · 

  3 min read
• Drug Development

  ContraVir Pharmaceuticals Initiated Dosing of Renally-Impaired Patients in First U.S. Trial With TXL

  October 19, 2017

   · 

  3 min read
• The Board of Directors of Nexstim Plc Resolved on Amendments of the Stock Options 2016 and on a New Stock Option Plan for the CEO

  Nexstim’s Board of Directors resolved on May 25, 2016 to issue stock options to the key employees and consultants of the company and its subsidiaries.

  October 19, 2017

   · 

  6 min read
• The New Orleans BioInnovation Center Holds the Fifth-Annual Innovation Louisiana Nov. 5 - 10

  The New Orleans BioInnovation Center presents the fifth-annual Innovation Louisiana, their flagship event series held each fall, to educate biotech innovators and showcase groundbreaking research being done around the state.

  October 19, 2017

   · 

  3 min read
• Biotech Bay

  Anatara Lifesciences Investor Presentation This Week

  Anatara Lifesciences is pleased to release its latest institutional roadshow presentation and market update that will be delivered to investors this week by CEO - chairman, Dr Mel Bridges and Co-Founder and Chief Scientific Officer, Dr Tracey Mynott.

  October 19, 2017

   · 

  1 min read